Identification of PDHX as a metabolic target for esophageal squamous cell carcinoma

被引：0
|
作者：
Inoue, Jun [1 ]
Kishikawa, Masahiro [1 ,2 ]
Tsuda, Hitoshi [3 ]
Nakajima, Yasuaki [4 ]
Asakage, Takahiro [2 ]
Inazawa, Johji [1 ,5 ]
机构：
[1] Tokyo Med & Dent Univ TMDU, Dept Mol Cytogenet, Tokyo, Japan
[2] TMDU, Dept Head & Neck Surg, Tokyo, Japan
[3] Natl Def Med Coll, Dept Basic Path, Tokorozawa, Saitama, Japan
[4] TMDU, Dept Surg Gastroenterol, Tokyo, Japan
[5] TMDU, Bioresource Res Ctr, Tokyo, Japan
来源：
CANCER SCIENCE | 2022年 / 113卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
J11-5-3
引用
收藏
页码：1348 / 1348
页数：1
相关论文
共 50 条
  • [1] Identification of PDHX as a metabolic target for esophageal squamous cell carcinoma
    Inoue, Jun
    Kishikawa, Masahiro
    Tsuda, Hitoshi
    Nakajima, Yasuaki
    Asakage, Takahiro
    Inazawa, Johji
    CANCER SCIENCE, 2021, 112 (07) : 2792 - 2802
  • [2] Metabolic reprogramming in esophageal squamous cell carcinoma
    Wang, Ziyi
    Sun, Xiangyu
    Li, Zehui
    Yu, Huidong
    Li, Wenya
    Xu, Yan
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [3] Identification of candidate target genes of genomic aberrations in esophageal squamous cell carcinoma
    Shen, Tian-Yun
    Mei, Li-Li
    Qiu, Yun-Tan
    Shi, Zhi-Zhou
    ONCOLOGY LETTERS, 2016, 12 (04) : 2956 - 2961
  • [4] Metabolic remodeling by TIGAR overexpression is a therapeutic target in esophageal squamous-cell carcinoma
    Chu, Jiahui
    Niu, Xiangjie
    Chang, Jiang
    Shao, Mingming
    Peng, Linna
    Xi, Yiyi
    Lin, Ai
    Wang, Chengcheng
    Cui, Qionghua
    Luo, Yingying
    Fan, Wenyi
    Chen, Yamei
    Sun, Yanxia
    Guo, Wenjia
    Tan, Wen
    Lin, Dongxin
    Wu, Chen
    THERANOSTICS, 2020, 10 (08): : 3488 - 3502
  • [5] Proteomic and Metabolic Signatures of Esophageal Squamous Cell Carcinoma
    Karagoz, Kubra
    Lehman, Heather L.
    Stairs, Douglas B.
    Sinha, Raghu
    Arga, Kazim Y.
    CURRENT CANCER DRUG TARGETS, 2016, 16 (08) : 721 - 736
  • [6] Mevalonate pathway is a therapeutic target in esophageal squamous cell carcinoma
    Shi, Jianxin
    Zhu, Ji
    Zhao, Heng
    Zhong, Chenxi
    Xu, Zhiyun
    Yao, Feng
    TUMOR BIOLOGY, 2013, 34 (01) : 429 - 435
  • [7] EpCAM, a Potential Therapeutic Target for Esophageal Squamous Cell Carcinoma
    Matsuda, Tatsuo
    Takeuchi, Hiroya
    Matsuda, Sachiko
    Hiraiwa, Kunihiko
    Miyasho, Taku
    Okamoto, Minoru
    Kawasako, Kazufumi
    Nakamura, Rieko
    Takahashi, Tsunehiro
    Wada, Norihito
    Kawakubo, Hirofumi
    Saikawa, Yoshiro
    Omori, Tai
    Kitagawa, Yuko
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : 356 - 364
  • [8] EpCAM, a Potential Therapeutic Target for Esophageal Squamous Cell Carcinoma
    Tatsuo Matsuda
    Hiroya Takeuchi
    Sachiko Matsuda
    Kunihiko Hiraiwa
    Taku Miyasho
    Minoru Okamoto
    Kazufumi Kawasako
    Rieko Nakamura
    Tsunehiro Takahashi
    Norihito Wada
    Hirofumi Kawakubo
    Yoshiro Saikawa
    Tai Omori
    Yuko Kitagawa
    Annals of Surgical Oncology, 2014, 21 : 356 - 364
  • [9] Exploring metabolic therapeutic targets for esophageal squamous cell carcinoma
    Inoue, Jun
    Kishikawa, Masahiro
    Asakage, Takahiro
    Inazawa, Johji
    CANCER SCIENCE, 2021, 112 : 385 - 385
  • [10] Identification of the key transcription factors in esophageal squamous cell carcinoma
    Zhang, Yuefeng
    Xu, Yanzhao
    Li, Zhenhua
    Zhu, Yonggang
    Wen, Shiwang
    Wang, Mingbo
    Lv, Huilai
    Zhang, Fan
    Tian, Ziqiang
    JOURNAL OF THORACIC DISEASE, 2018, 10 (01) : 148 - +
12345